← All diseases Liver, kidneys and digestion

Primary sclerosing cholangitis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (32)Meta-analysis (9)Treatment guideline (7)Phase 3 study (6)Systematic review (6)Randomized trial (4)Clinical trial (182)Review article (287)Early study (phase 1 or 2) (23)Case reports (179)Laboratory or animal study (27)Commentary or editorial (54) Studies currently recruiting participants only (30)

Filter

Publications and studies (1452)

• Automated image analysis of keratin 7 staining can predict disease outcome in primary sclerosing cholangitis. (2023/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neonatal ichthyosis-sclerosing cholangitis syndrome: report of a novel mutation and a review of the literature. (2023/04/01) ♡
• Nigella sativa seeds mitigate the hepatic histo-architectural and ultrastructural changes induced by 4-nonylphenol in Clarias gariepinus. (2023/03/13) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. What Is the Risk? Epidemiology and Evidence for Surveillance Regimens. (2023/03/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bile Acids and Biliary Fibrosis. (2023/03/02) ♡
• IgG4-related autoimmune liver disease. (2023/03/01) ♡
• Risk stratification in primary sclerosing cholangitis. (2023/03/01) ♡
• Next-generation sequencing mutation analysis on biliary brush cytology for differentiation of benign and malignant strictures in primary sclerosing cholangitis. (2023/03/01) ♡
• Disease burden in primary sclerosing cholangitis in the Netherlands: A long-term follow-up study. (2023/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The microbiota and the gut-liver axis in primary sclerosing cholangitis. (2023/03/01) ♡
• A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis. (2023/03/01) ♡
• Safety and efficacy of switching to pemafibrate from bezafibrate in patients with chronic liver disease (2023/03/01) ♡
• Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis. (2023/03/01) ♡
• Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop. (2023/03/01) ♡
• Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital. (2023/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Post-Transplant Immunosuppression in Autoimmune Liver Disease. (2023/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Can a mucosal microbiota signature predict disease severity, survival, and disease recurrence in PSC? (2023/03/01) ♡
• Outcomes of endoscopic retrograde cholangiography and percutaneous transhepatic biliary drainage in liver transplant recipients with a Roux-en-Y biliary-enteric anastomosis. (2023/02/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gastrointestinal disorders and intestinal bacteria: Advances in research and applications in therapy. (2023/02/07) ♡
• Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of an RARE-LIVER online survey. (2023/02/01) ♡
• Diagnostic pitfalls and the value of fluorescence in situ hybridization as an adjunct to cytologic evaluation of bile duct brushings in patients with primary sclerosing cholangitis. (2023/02/01) ♡
• Mesenchymal stem cells: A novel treatment option for primary sclerosing cholangitis. (2023/02/01) ♡
• Genetic link between rheumatoid arthritis and autoimmune liver diseases: A two-sample Mendelian randomization study. (2023/02/01) ♡
• Hepatic Dry Copper Weight in Pediatric Autoimmune Liver Disease. (2023/02/01) ♡
• Liver-specific deletion of microRNA-34A alleviates ductular reaction and liver fibrosis during experimental cholestasis. (2023/02/01) ♡
• Prognostic Significance of Severe Vitamin D Deficiency in Patients with Primary Sclerosing Cholangitis. (2023/01/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone. (2023/01/16) ♡
• Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury. (2023/01/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mechanisms of pruritus in cholestasis: understanding and treating the itch. (2023/01/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Systematic review: microbial manipulation as therapy for primary sclerosing cholangitis. (2023/01/01) ♡
• Fever of unknown origin due to Coxiella burnetii, an unexpected guest in primary sclerosing cholangitis. (2023/01/01) ♡
• Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis. (2023/01/01) ♡
• The M-ANNHEIM-AiP-Activity-Score is useful for predicting relapse in patients with type 1 autoimmune pancreatitis. (2023/01/01) ♡
• Epidemiology and updated management for autoimmune liver disease. (2023/01/01) ♡
• Liver biopsy in inflammatory bowel disease patients with sustained abnormal liver function tests: a retrospective single-center study. (2023/01/01) ♡
• A prospective pilot study of a gluten-free diet for primary sclerosing cholangitis and associated colitis. (2023/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: dietary interventions to understand and treat primary sclerosing cholangitis-is gluten-free diet a starting point? (2023/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Endothelin Signaling Mediates Biliary-Endothelial Crosstalk in Primary Sclerosing Cholangitis. (2023/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Cilofexor in Adults With Primary Sclerosing Cholangitis (2023-11-29) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT) (2023-10-11) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases (2023-10-02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects (2023-09-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis (2023-07-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis (2023-07-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. PSC Clinical Epidemiology in China (2023-05-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cholangioscopy in Primary Sclerosing Cholangitis (PSC) (2023-01-25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Secondary sclerosing cholangitis and IgG4 sclerosing cholangitis - A review of cholangiographic and ultrasound imaging. (2022/12/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature. (2022/12/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Secondary sclerosing cholangitis in a young COVID-19 patient resulting in death: A case report. (2022/12/27) ♡
• Protective potential of the gallbladder in primary sclerosing cholangitis. (2022/12/17) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.